Drug Updates

Drug updates provide the latest information and relevant warnings and notifications.

Update on Drugs and Drug News: March, 1998

Update on: Famciclovir Famvir® Acyclovir sodium Zovirax® Calcipotriol Dovonex® Thalidomide 50 mg Thalomid® Finasteride 1mg tablets Propecia® Aids vaccine Aidsvax® phase III, Indinavir Crixivan® Calcipotriene 0.005% Dovonex®ointment

Update on Drugs and Drug News – March 2007

Update on Diclofenac Sodium 3% Gel Solaraze®, Retapamulin Ointment 1% Altabax™, Calcium Hydroxylapatite Microspheres in Water-based Gel Radiesse®, Rose Bengal Disodium 10% PV-10, and Taxane Potentiator STA-4783.

Update on Drugs & Devices: March – April 2019

Latest drug update covers Pembrolizumab, Oral JAK + SYK dual inhibitor, Lidocaine 7% + tetracaine 7% local anesthetic cream and PrabotulinumtoxinA-xvfs.

Update on Drugs and Drug News – February 2008

Update on Anti-psoriatic Agent Ustekinumab CNTO 1275, Anti-arthritic Agent Tocilizumab Actemra®, Neurotoxin Botulinum Toxin Type A Reloxin®, and news from The National Institute for Health and Clinical Excellence (NICE) in the UK.

Update on Drugs & Devices: November – December 2018

Update on PrabotulinumtoxinA, Tretinoin 0.05% lotion, Cemiplimab-rwlc, Autologous fibroblast gene therapy, Oral JAK3 inhibitor, Halobetasol propionate 0.01% lotion, Sarecycline hydrochloride tablets and HPV 9-valent vaccine.

Update on Drugs and Drug News: February 2012

Update on drugs, approval dates, and comments. Adapalene 0.1% + benzoyl peroxide 2.5% gel (Epiduo®), Hyaluronic acid-based dermal filler (Belotero® Balance), Drospirenone 3 mg + ethinyl estradiol 0.02 mg (Vestura™) are covered.

Update on Drugs and Drug News: May-June 2014

Update on Brimonidine tartrate 0.33% topical gel (Onreltea®Mirvaso®), Apremilast tablets (Otezla®), Miltefosine capsules (Impavido®), Hydrogel wound dressing (Loutrex®), Omalizumab for SC injection (Xolair®), Propranolol hydrochloride oral solution (Hemangeol™), Microbicide-coated condom Vivagel® (SPL7013 gel)

Update on Drugs and Drug News: March-April 2016

Update on (Beteflam™), Human papillomavirus (HPV) 9-valent vaccine, recombinant (Gardasil®9), (Imlygic®), Pembrolizumab IV injection (Keytruda®), Adalimumab SC injection (Humira®), Secukinumab SC injection (Cosentyx®), Ustekinumab SC injection (Stelara®), and Nivolumab + ipilimumab (Opdivo® + Yervoy®).

Update on Drugs and Drug News: September-October 2015

Update on Nivolumab IV infusion (Opdivo®), Pembrolizumab IV infusion (Keytruda®), Sonidegib phosphate capsules (Odomzo®), Azelaic acid 15% foam (Finacea® Foam), Adapalene 0.3% + benzoyl peroxide 2.5% gel (Epiduo® Forte), Deoxycholic acid injection (Belkyra™), Hyaluronic acid gel injectable dermal filler (Restylane® Lyft with Lidocaine), Dermal filler with calcium hydroxylapatite (CaHA) + integral 0.3% lidocaine (Radiesse® (+)

Update on Drugs and Drug News: May-June 2016

Update on Betamethasone dipropionate 0.05% spray (Sernivo™), Dapsone 7.5% gel (Aczone®), Cobimetinib + vemurafenib (Cotellic™ + Zelboraf®), Botulinum toxin type A for injection (Bocouture®), Calcipotriol + betamethasone dipropionate foam (Enstilar®), (Talz®), (Inflectra™), (Pruridexin™), and (Dermadexin™)

Update on Drugs and Drug News: January-February 2016

January and February 2016: Update on drugs, approval dates, and comments. Autologous cell suspension (ReCell® ReGenerCell® ReNovaCell®), Calcipotriene 0.005% + betamethasone dipropionate 0.064% foam (Enstilar®), Ipilimumab (Yervoy®), Talimogene laherparepvec (T-Vec) oncolytic virus therapy (Imlygic™), Cobimetinib + vemurafenib (Cotellic™ + Zelboraf®), Dabrafenib + trametinib (Tafinlar® + Mekinist®), Nivolumab injection (Opdivo®) are covered.

Update on Drugs & Drug News August 2005

Updates on: Infliximab Remicade®Cyproterone Ethinyl Diane-35

Update on Drugs and Drug News: February, 2000

Update on: Aminolevulinic Acid Levulan Photodynamic Therapy G-3139 Genta Inc Moxifloxacin HCl Avelox Ciclopirox Loprox 8% Topical Solution 5-fluorouracil Solex Allovectin-7 Vical Inc

Update on Drugs and Drug News: December 2002

Updates on: Prasterone Prestara™ Valacyclovir HCl Valtrex® Norelgestromin/Ethinyl Estradiol Transdermal System EVRA®

Update on Drugs and Drug News: July-August 2010

Update on drugs, approval dates, and comments. Belimumab (Benlysta®), Adapalene 0.1% gel, Antiseborrheic compound (K301/Kaprolac®) are covered.

Update on Drugs and Drug News – February 2006

Update on Doxycycline Oracea® CollaGenex, Hydrogel Dressing MimyX™ Cream Stiefel Laboratories, and Aluma™ Skin Renewal System with FACES™ Lumenis.

Update on Drugs and Drug News: December, 1997

Update on: Mupirocin calcium cream 2% Bactroban Cream® Butenafine cream Mentax®Becaplermin gel 0.01% Regranex®Finasteride 1mg tablets Propecia®Minoxidil 5% Rogaine Extra Strength for Men® Dermagraft® Graftskin® (apligraf) UV light as carcinogen

Update on Drugs & Drug News October 2005

Updates on: Tigecycline Tygacil™ Terbinafine HCl Lamisil® Tablets Moxifloxacin HCl Avelox® Adalimumab Humira®

Update on Drugs and Drug News: May 2011

Update on drugs, approval dates, and comments. Belimumab (Benlysta®), Ipilimumab (Yervoy™), Imiquimod 3.75% Cream (Vyloma™) are covered.

Update on Drugs and Drug News: March-April 2018

Update on Drugs & Devices March and April 2018: Hydrogen peroxide topical solution Eskata™, Mepolizumab for SC injection Nucala® GSK, Brentuximab vedotin for IV use Adcetris®, CoolSculpting®, (PDF) patch DeScribe® PFD Patch, Adhesive patch for melanoma detection Pigmented Lesions Assay (PLA)

Update on Drugs and Drug News: May 2009

Update on Alitretinion (Toctino®), Pralatrexate, Benzyl Alcohol Lotion 5%, and Botulinum Toxin – Type A (Azzalure®) and news on Efalizumab (Raptiva®).

Update on Drugs and Drug News: November 2009

Updates on Ustekinumab Stelara® Centocor Ortho Biotech, Romidepsin ISTODAX® Gloucester Pharmaceuticals and news from US FDA.

Update on Drugs and Drug News: February, 1999

Update on: Imiquimod Aldara® Cream Abacavir Ziagen® Finasteride 1 mg tablets Propecia® Lyme disease vaccine LYMErix®Aldesleukin Proleukin®Varicella Vaccine Varivax®Minoxidil Taisho

Update on Drugs & Devices: September – October 2018

Updates on Binimetinib + Encorafenib (Mektovi® + Braftovi®), Crisaborole 2% ointment (Eucrisa™), Glycopyrronium tosylate 2.4% cloth (Qbrexza™), Secukinumab for SC injection (Consentyx®), Tecovirimat capsule (Tpoxx), Diacerein 1% ointment (CCP-020), Migalastat capsule (Galafold™), Mogamulizumabkpkc for IV use (Poteligeo®)

Update on Drugs and Drug News: January-February 2015

Update on Apremilast tablets (Otezla®), Collagenase clostridium histolyticum for injection (Xiaflex®), Afamelanotide 16 mg subcutaneous bioresorbable implants (Scenesse®), Clindamycin phosphate 1.2% + benzoyl peroxide 3.75% gel (Onexton™), Dupilumab SC injection, Apremilast tablets (Otezla®).

Update on Drugs & Devices: September – October 2021

The update covers: Tazarotene lotion, 0.045% - Arazlo™ (Bausch Health), Anifrolumab-fnia IV use - Saphnelo™ (AstraZeneca), Immune globulin intravenous (human) 10% - Octagam® 10% (Octapharma), Odevixibat capsule - Bylvay™ (Albireo Pharma) and other treatments

Update on Drugs and Drug News: January 2000

Update on: Pyrethrins/Piperonyl butoxide Rid aerosol foam mousse Fluocinolone acetonide 0.01% Derma-Smoothe/FS Quinupristin/ Dalfopristin Synercid IV Rid Lice Egg Loosener Gel Tacrolimus Protopic Ointment Docosanol

Update on Drugs and Drug News: April 2002

Update on drugs: Fluocinolone Acetonide, Hydroquinone, Tretinoin Tri-Luma®Pimecrolimus Elidel®Clindamycin, Zinc Zindaclin™ Gel Voriconazole Vfend® Imiquimod Aldara® 5% Cream

Update on Drugs and Drug News: July-August 2011

Update on drugs, approval dates, and comments. Human papillomavirus (HPV) test (Cobas® HPV Test Cobas® 4800 System), Betamethasone valerate 0.12% foam (Luxiq®) are covered.

Update on Drugs & Devices: May – June 2019

Latest drug update covers Pembrolizumab for IV injection (Keytruda®, Merck & Co.), Guselkumab for SC injection (Tremfya®, MorphoSys/Janssen), Dupilumub for SC injection (Dupixent®, Regeneron), and Risankizumab for SC injection (Skyrizi™, AbbVie).

Skin Treatments Introduced in 2017

A look back at skin treatments introduced in 2017 for the following type/class of therapy: Antibiotic agents, anti-cancer agents, atopic dermatitis, dermal fillers, fabry disease, hereditary angioedema, herpes zoster, hidradenitis suppurativa, psoriasis, psoriatic arthritis, rosacea...

Update on Drugs and Drugs News June 2005

Updates on: Pimecrolimus and Tacrolimus Elidel® Cream and Protopic® Ointment Elidel®: Novartis Protopic®: Miltefosine Impavido®

Update on Drugs and Drug News: July-August 2014

Update on drugs Metronidazole 1.3% vaginal gel (Actavis plc), Ecallantide for SC injection (Kalbitor®), Dalbavancin for IV injection (Dalvance™), Taliglucerase alfa for IV injection (Elelyso™), and Efinaconazole 10% topical solution (Jublia®)

Update on Drugs and Drug News: February 2011

Update on drugs, approval dates, and comments. Human papillomavirus quadrivalent (Types 6, 11, 16, and 18) recombinant vaccine (Gardasil®), Daptomycin for injection (Cubicin®) are covered.

Update on Drugs and Drug News – December 2007 – January 2008

Update on Loratadine Dry Syrup 1% Claritin® Schering-Plough, Valacyclovir Hydrochloride TEVA Pharmaceutical Industries, and news about Anti-dandruff, anti-acne and anti-melanoma agents.

Update on Drugs and Drug News: July 2012

Update on drugs, approval dates, and comments. CIP-Isotretinoin (Absorica™), Tazarotene 0.1% foam (Fabior™), Butoconazole nitrate 2% vaginal cream, Multisource radiofrequency aesthetic device (Glow by EndyMed™), Low-level laser for circumferential upper arm reduction (Zerona®) are covered.

Update on Drugs and Drug News – May 2008

Update on Triphendiol (formerly NV-196), Cyclic pentapeptide vascular-targeting agent ADH-1, Certolizumab pegol Cimzia® and drug news from around the world.

Update on Drugs and Drug News: February, 1998

Update on: Diclofenac sodium Solarase Gel 3% Trovafloxacin (oral) Alatrovafloxacin (IV) Trovan Zidovudine 300 mg/ lamivudine 150 mg Combivir Hydroquinone 4%, glycolic acid & an antioxidant complex. Lustra 10% Docosanol Cream Bleomycin ANDA Leprosy vaccine Minocycline Minocin Protease inhibitor side-effects

Update on Drugs and Drug News: January, 1999

Update on: Lidocaine 2.5%, prilocaine 2.5% Emla® patch Cyclosporin SangCya®Metronidazole lotion 0.75% Metrolotion® Imiquimod Aldara® 2-octylcyanoacrylate Dermabond Topical Skin Adhesive®Alitretinoin gel 0.1% Panretin®Loratidine Claritin®Cetirizine Zyrtec®Penciclovir Denavir®Lyme disease vaccine LYMErix®

Update on Drugs and Drug News: January 2013

Update on Tofacitinib citrate tablets (Xeljanz®), Lidocaine 7% + tetracaine 7% cream (Pliaglis®), Calcipotriene 0.005% + betamethasone dipropionate 0.064% topical suspension (Taclonex®), Tocilizumab (Actemra®), C1 esterase inhibitor (human) (Cinryze®), and Doxycycline monohydrate 40 mg capsules (Apprilon®)

POPULAR

Advertisement